Title XELOX FOR SALIVARY GLAND CANCERS

NCT00101075 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Head and Neck Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]